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I A STUDY OF THE 'ARTIFICALLY-INDUCED' AND ’NATURAL'
I
I  LUPUS ERYTHEMATOSUS CELL PHENOMENA
j
I  CHAPTER I
II
INTRODUCTION
i
I
The discovery and description of the L.E. (Lupus Erythema­
tosus) cell phenomenon by Hargraves (l) in 19^ 8 has provided a valuable 
tool in the diagnosis of systemic lupus erythematosus. This phenomenon 
has come to be recognized as a distinctive manifestation of this disease. 
Although most investigators consider the production of this cell as a 
specific characteristic of systemic lupus erythematosus, there is 
evidence that similar cellular reactions may occur in various other con-; 
ditions. Indeed, this preparation would appear to merit study as a 
basic cellular response to injury.
The L.E. phenomenon has been the subject of much investigation. 
Studies which have been concerned with the mechanisms of this phenomenon 
have clearly shown a protein factor in the blood of patients with 
systemic lupus erythematosus to be responsible for initiating the phe­
nomenon. Several mechanisms have been postulated to explain the events 
of nuclear break-down preceding the L.E. cell formation; however, the 
serum factor that initiates the cellular mechanisms has been isolated 
and grossly identified.
1
2Haserick (2), utilizing chemical and electrophoretic separation 
techniques, has demonstrated that a serum gamma globulin fraction from i 
patients with systemic lupus erythematosus initiates the L.E. phenomenon 
in normal blood and is apparently the activating factor in the L.E. 
phenomenon. Since the action of this protein factor is to initiate pro- ' 
cesses inside of the cell which cause nuclear break-down, it would seem ' 
likely that other substances might be found that would initiate similar ; 
cellular processes.
Inderbitzen (3) described an ester of polyvinyl alcohol poly- 
sulfonic acid (PVAS) which induced the L.E. phenomenon artificially in 
normal blood. He found that when this compound was incubated with normal 
serum, a factor was liberated which, when added 'in vitro' to normal 
blood, would initiate the L.E. phenomenon. The cells produced in this 
artificial L.E. phenomenon were morphologically identical to the natural 
L.E. cells and the mechanisms by which they developed were apparently 
the same with the exception of the initiating factor. It was found that ; 
gamma globulin was in some way altered or combined with PVAS in the 
normal serum, when incubated, producing this artificial initiating 
factor.
In the present study a compound, cetyltrimethylammonium 
bromide (referred to hereafter as CTAB), was found which will precipitate 
portions of the beta and gamma globulin fractions when added to normal 
serum. This compound was injected subcutaneously into experimental 
animals to determine its 'in vivo' effect upon tissue glycoproteins. It 
was noted that CTAB produced extremely rapid necrosis at the site of 
injection. Microscopic examination of this tissue revealed massive
3hyâlnization with the production of hematoxylin-staining bodies. Since 
the hematoxylin-staining bodies and the inclusion bodies of L.E, cells 
have been shown by Lee (4) to be chemically and optically identical, it 
was decided to determine the effect of CTAB on white blood cells.
When CTAB was added ’in vitro' to normal blood it was found 
to provoke nuclear depolymerization in polymorphonuclear leukocytes, 
resulting in the formation of L.E.-like cells.
Study of this artificially-induced L.E. phenomenon which was 
produced in normal blood by CTAB and its similarities and relationships 
to the L.E. phenomenon of systemic lupus erythematosus, was proposed in 
amplification of the above findings.
CHAPTER II
HISTORY
Hargraves, Richmond and Morton (l) in 1948 first described an |
I
unusual cell which they found in heparinized bone marrow specimens from |
individuals with systemic lupus erythematosus. These cells developed |
!
when the bone marrow specimens were allowed to stand at room temperature! 
for two hours. This cell, called the L.E. cell, was described as a 
mature polymorphonuclear neutrophil containing an amorpborus, structure­
less inclusion body. The inclusion body showed slightly altered nuclear; 
staining characteristics and displaced the nuclei of the segmented 
neutrophil to the periphery of the cell. Since the discovery of this 
phenomenon inclusion bodies have been reported in various white blood 
cells, including band forms, eosinophils, monocytes, lymphocytes and 
myelocytes (4-8).
The L.E. cell inclusion body has been regarded as representing 
either phagocytized nuclear material from other cell nuclei, in which 
the chromatin structures have undergone depolymerization, or as the 
result of autolysis of one or more nuclear segments of the involved cell. 
Haserick (9) suggested that the inclusion bodies might consist of 
precipitated protein or that they might be of megakaryocytic or platelet| 
origin.
5Lupus erythematosus cell inclusion bodies are now generally 
accepted to be of nuclear origin. Differential staining techniques with 
Fuelgen and methyl green have shown them to be composed largely of de- 
polymerized desoxyribose nucleic acid, (lO). Berman et al (5) expressed 
doubt as to whether this material originates from the nuclei of lympho­
cytes or neutrophils ; but that it was probable that they arose from both:
Neutrophils containing ingested red cells (ll), precipitated 
protein material (12), or fungus forms (13) are not to be considered j 
L.E. cells; yet they have been reported as a source of error (14).
When destructive changes occur in cellular nuclei, the cell, j
i
acting as a foreign object, may stimulate phagocytosis by normal phago- I  
cytic cells. As a result of such destructive changes, generally referred 
to as ’lysis*, the cell nuclei lose their structural chromatin patterns 
and appear as relatively homogeneous masses. After the nuclear and 
cytoplasmic membranes rupture, the lysed nuclear mass is freed from other 
cellular components and will often exert a chemotactic attraction to 
wandering phagocytes. This phenomenon of lysis is referred to as nucleo­
lysis or chromatolysis and the free masses have been called "amorphous 
masses" (l4), "globs" (4,15) and "lysed nuclear masses" (16). The agent 
responsible for the lytic activity occurring in the L.E, phenomenon is 
known as the L.E. factor.
If a free mass of depolymerized nucleoprotein is chemotactic, 
it will attract phagocytic cells which agglutinate on the mass, and 
attempt to engulf it. In positive L.E. cell preparations these agglu­
tinated clumps of cells are prominent. They appear characteristically 
as a central core of free nuclear material with a surrounding group of :
6phagocytes making up the "rosette" described by Haserick (17).
Klemperer (I8) studying the tissue from patients with systemic} 
lupus erythematosus, found that hematoxylin-staining bodies were a con- !
sistent histological finding in this disease. Subsequent cytochemical !
I
studies showed these hematoxylin-staining bodies to be composed of depoly­
merized desoxyribose nucleic acid (k), {
Lee, Michael and Vural (U), employing the photometric methods :
!
used in the study of the hematoxylin-staining bodies, demonstrated that | 
the inclusion body of the L.E, cell also contains depolymerized desoxy- '
ribose nucleic acid. They concluded that this lysed nuclear mass forming
1
the L.E. cell inclusion body was optically and chemically identical to 
the hematoxylin-staining bodies.
The L.E. cell phenomenon has been the subject of much investi­
gation. Investigations have been largely concerned with different 
methods of reproducing or enhancing the phenomenon, simplification of 
the procedure and the identification of factors involved in the phen­
omenon (6,8,19-32).
Snapper (27), Walsh (33) and Weiss (3*4-) consider the L.E, cell 
phenomenon specific for acute disseminated lupus erythematosus, while 
Berman ($), Beerman (35) and Lee (36) maintain that it is a valuable 
confirmatory tool in the diagnosis but that the test is not an absolute 
diagnostic criterion of the disease. Both groups, however, admit that 
it cannot always be demonstrated in the acute and subacute forms of the 
disease and only rarely occurs in the chronic form.
Lupus erythematosus cells have been observed, though sometimes 
in small number in a variety of unrelated diseases, such as leukemia (37);
7pernicious anemia in relapse (5), dermatitis hypertiformis (5)^  acquired 
hemolytic anemia (38), chronic hepatitis (39"*^ l)> penicillin reactions 
(^ 2^ 3); multiple myloma moniliasis miliary tuberculosis (46),
periarteritis nodosa (47) and scleroderma (48). Apart from disseminated! 
lupus erythematosus perhaps the highest incidence of positive tests have! 
been found in chronic rheumatoid arthritis (36,49,50). The phenomenon !
I
has also been noted to become positive during the severe relapse which 
often follows the withdrawal of cortisone therapy (50) and it has been 
suggested that systemic lupus erythematosus may have been coexistent in 
these patients (5I).
Lee (38) has suggested that the phenomenon may represent an 
abnormal enzyme reaction but did not expound this postulation. It has 
been found to be positive in circumstances where there is active tissue 
destruction (l), disturbances of the antibody mechanisms (4l) or the 
phenomenon may be related to hypersensitivity without the manifestations 
of lupus erythematosus (43).
The instigating factor for the L.E. phenomenon resides in the 
plasma, serum and probably all tissue fluids of the patient. Positive 
tests have been reported using Joint effusions (l4), pleural effusions 
(52), pericardial effusions (53); cerebro-spinal fluid (54) and urine
(55,56).
Nucleolysis occurs as the result of the L.E. factor acting 
upon living leukocytes, independent of the source of these leukocytes. 
However, a difference in susceptability to lysis and phagocytosis of the 
cells from a variety of human and animal sources has been observed (57). 
The greatest species difference observed is that actual phagocytosis.
8productive of the L.E. cell, is unconunon in dog bone-marrow preparations, 
while rosette formation is prominent and diagnostic. The L.E. factor 
may be transferred passively to laboratory animals (56), and will pass i 
through the placental barrier (59), although it need not be associated 
with symptoms of lupus erythematosus in the infant.
Hargraves (I6) suggested that the L.E. cell phenomenon re­
action in blood may be initiated by the breakdown of platelets. This 
speculation was based on the observation that the phenomenon did not 
occur in vivo. Also, in three patients after splenectomy for hyper- 
splenism (20) there developed symptoms of acute disseminated lupus 
erythematosus with positive L.E. tests. Further confirmation of the 
role of platelets in this phenomenon was reported, stressing the im­
portance of blood coagulation in accentuating the reaction (60,6l). 
Anticoagulants do not enhance the formation of the L.E. cells and may 
actually reduce the intensity of the reaction (38,60,61).
Although the phenomenon was thought to take place only in 
vitro, Chornet and his associates (62) found L.E. cells in peripheral 
blood smears from patients with advanced systemic lupus erythematosus. 
Haserick (2) had previously reported that the L.E. phenomenon was 
observed after 12-13 minutes of incubation in some instances. Friedman 
and his group (63) rationalized that hypoxia and stasis were probably 
present in the patient with advanced systemic lupus erythematosus and 
hypoxia was important in the activation of the L.E. factor. By con­
stricting a finger of patients with systemic lupus erythematosus for 20 
minutes and studying direct blood films made from blood of the con­
stricted finger, they were able to demonstrate the L.E. phenomenon
9’in vivo’.
On rare occassions L.E. cells have been found in freshly drawn 
blood smears (62,61»-) and in sections of tissue obtained at autopsy (8, ■ 
10), In a study of spleen obtained at autopsy from a patient with 
systemic lupus erythematosus, as diagnosed by the L.E, phenomenon, the 
nuclei of the spleen cells to a depth of three to four cell layers had 
lost their chromatin patterns, and homogenization with swelling was 
evident. Cells deeper in the splenic tissue contained normal-staining 
nuclei. i
Electrophoretic analysis and immunological studies of serum 1 
proteins from individuals with systemic lupus erythematosus indicate 
that the L.E, factor is contained in the gamma globulin fraction (2,5,9)'. 
Nucleophagocytosis as well as phagocytosis of various tissue cells have 
been produced by injecting this antigen into test animals and stimulating 
antibody formation. The serum of such animals will produce nucleophago­
cytosis when mixed with normal cells from another animal.
The L.E. factor is quite stable in sterile serum and may be 
preserved for a year or longer in the frozen state (l4), but it is in­
activated by heating to 65° C. or by bacterial contamination (2). The 
phenomenon can be inhibited by the addition of para-aminobenzoic acid 
and L.E. antibodies developed in rabbits against the specific gamma 
globulin, but it is not inhibited by cortisone, testosterone, estradiol, 
progesterone or control antibodies developed in rabbits against normal 
human plasma proteins (2,65).
Kuemick (I5) has postulated that enzymatic activity of des- 
oxyribonuclease may cause depolymerization of desoxyribose nucleic acid ;
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due to the lack of an inhibitor of the enzyme. He suggested that the 
L.E. factor inactiviates an inhibitor of desoxyribonuclease which normal­
ly occurs in polymorphonuclear leukocytes. When the enzyme inhibitor is 
inactivated, depolymerization of nucleoproteins occurs. Attempts to I  
demonstrate that serum desoxyribonuclease participates in the L.E. cell - 
phenomenon have not been successful (66), although a nuclease inhibitor | 
derived from normal human leukocytes inhibits the phenomenon (67).
Structures similar to L.E. cells have been produced with 
leukocytic antiserum (68), de soxyribonuclease (69), polyvinyl alcohol
I
polysulfonic acid ester (3), virus cultures recovered from patients withj 
lupus erythematosus (70). They have also been reported following pro­
longed administration of hydralazine in hypertension (7I). Moolten and 
Clark (70) isolated a virus from each of six patients with systemic lupus 
erythematosus. In each case, after multiple successive incubations in ; 
chick embryos, they were able to reproduce the L.E. cell phenomenon by 
mixing the virus culture with normal blood cells.
Gastello, Fernandez and Reamedois (58) reported the L.E. cell 
phenomenon in the blood of guinea pigs that had received repeated in­
jections of 2 to 5 cc of whole blood from patients with systemic lupus 
erythematosus. Examination of the tissue from these experimental 
animals revealed changes similar to those found in material obtained from 
human patients with systemic lupus erythematosus and it is of interest 
that these changes could be induced only in female guinea pigs.
Since the L.E. phenomenon is the result of a biochemical re­
action, it has been proposed that chemical and biological agents other 
than the L.E. factor might induce the phenomenon (l), Under experimental
11
conditions this was accomplished by Inderbitzen (3) who utilized the 
anticoagulant, polyvinyl alcohol polysulfonic acid ester (PVAS, Roche), 
as a nucleolytic agent. Experiments with PVAS yielded cells indistin­
guishable from the L.E. cell of systemic lupus erythematosus. A serum 
factor residing in the gamma globulin fraction was found to take part in 
the reaction. This artificial L.E. factor was produced by heating the 
gamma globulin fraction or whole serum with PVAS for about 30 minutes at ^
59° centigrade. If coagulation of the blood was inhibited by heparin 
before PVAS was added, the phenomenon did not occur. Although the cell­
ular changes were morphologically identical to the genuine L.E. pheno­
menon, the serum had been subjected to physical processes and a foreign i  
substance that does not occur physiologically. However, such an ex­
perimental approach might be fruitful for the study of fundamental I
mechanisms in the L.E. phenomenon of systemic lupus erythematosus.
CHAPTER III
I
j METHODS
The animals used in this study were normal, healthy dogs, i
i
1
rabbits, mice and rats of both sexes. These animals, supplied from the : 
animal quarters at the University of Oklahoma School of Medicine, were 
maintained as a source of normal blood for artificial L.E. preparations 
and as a source of donor cells and serum for the natural L.E. prepara­
tions. Blood from rats, mice and rabbits was drawn, under light ether 
anesthesia, by cardiac puncture; blood from dogs was obtained by veni­
puncture without anesthesia.
Patients included in this study were selected at random from 
the outpatient clinics of the University Hospitals, the Oklahoma County 
Farm Hospital, and McBride Bone and Joint Hospital, all of Oklahoma City, 
Oklahoma. This study group included both sexes emd represented several 
age groups. They were further classified according to their medical 
diagnoses. Normal healthy individuals, used for controls, were also in­
cluded. Stock L.E. serum was obtained from three female patients with 
systemic lupus erythematosus. Blood from these patients was drawn by 
venipuncture into a clean, dry syringe, transferred to a centrifuge tube 
and allowed to clot and separate. After centrifugation, the serum was 
decanted from the clot and preserved by freezing until needed.
12
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L.E. Prep. (Lupus Erythematosus Preparation)
The technique for L.E. preparations vas adapted from the method 
hy Zimmer (6l).
Blood for L.E. preparations was drawn by venipuncture or car­
diac puncture into a clean, sterile, dry syringe through a 20 gauge 
needle. Anticoagulants were not used unless specified. After drawing 
the blood the needle was removed from the syringe and two ml of blood was 
placed into a clean 15 x 100 mm serological tube. The tube was then 
corked and allowed to stand at room temperature (28-3O degree C.) for two 
hours. Ordinarily at the end of this period of time the blood had 
clotted and satisfactory separation of the plasma had occurred. The clot 
was then broken loose from the wall of the tube with a wooden applicator 
stick, and with the other contents of the tube, poured onto a 40 gauge 
brass-wire sieve screen. A soft rubber stopper was used to mash the clot 
gently upon the screen, which allowed the serum and cells to pass through 
into a glass petri dish while the fibrin strands were left behind on the 
sieve. In the event that a clot had not formed at the end of two hours, 
the blood was gently stirred with a wooden applicator stick and the 
mixture regarded from this point on as if it had been defibrinated with 
the screen wire.
The serum-cell mixture was pipetted into a 1.5-2.0 x 100 mm 
capillary melting point tube until the latter was 3/4ths full. The tube 
was then heat-sealed at one end and centrifuged at maximum speed (ap­
proximately 1610 R.C.F.) for five minutes in an International Clinical
Centrifuge. This treatment was usually sufficient to provide good separa­
tion of the huffy coat of vhite blood cells. Wire-cutting pliers were
Ik
used to break the capillary tube about $-6 mm above the huffy coat and 
also at the end which had been beat sealed. The serum and huffy coat 
were gently smeared onto a clean glass microscope slide, and the remain­
ing red cells were discarded. The huffy coat film was allowed to dry. 
The dry slide could then be stored, ready for staining whenever desired.
Capillary tubes were employed in this study, as described, in 
place of the more commonly used hematocrit tubes. They were considered 
more satisfactory because of convenience, low cost, and the relatively 
small amount of specimen required. Each tube contained a sufficient 
amount for one good slide.
In some experiments it was necessary to alter certain factors i 
such as time, temperature, concentration, etc.; however, when pertinent 
alterations were employed they are described.
Stains
Four histological staining procedures were used in this study, 
Wright’s and Giemsa's stains were utilized for identification of general 
cell morphology. Methyl green-pyrinon Y and the Feulgen reaction were 
employed for histochemical identification of desoxyribose and ribose 
nucleic acids.
Wright’s Stain
A commercially-available Wright’s stain was used (Banco). The 
dry slide was covered with staining solution for a period of two minutes. 
Two volumes of distilled water were then added to the slide and allowed 
to stand for an additional five minutes. The slide was then rinsed with 
fresh distilled water to remove excess stain, emd allowed to drain dry.
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Glensa Stain
The Giemsa stain used was commercially*available as the stock 
solution (Harleco). Fresh dilutions of the stock solution were made
!
immediately before the stain was to be used. For Giemsa staining the 
dried smears were fixed in 100^  Methyl alcohol for five minutes, and 
allowed to drain dry before staining. They were immersed in the stain­
ing solution for one hour, rinsed in the buffer solution twice, drained,j 
and allowed to dry.
Methyl Green-Pyronin Y
j
This staining reagent was prepared according to the method of ' 
Perry and Reynolds (72). It was used in attempts to differentiate 
desoxyribose and ribose nucleic acids in the cytoplasm, nuclei and cyto­
plasmic inclusion bodies of the cells. In preparation for this stain the 
slides were fixed in Camoy’s (73) fixative solution for ten minutes and; 
stained according to the author’s suggested procedure. ,
Feulgen
The Schiff reagent employed in this reaction was prepared by 
the "Cold Schiff" method 8uid the procedure of the Feulgen reaction, as 
described by Lillie (7^ )> was followed. This stain was used as a more 
specific indicator of desoxyribose nucleic acid.
All slides were dried after staining and stored for future 
microscopic examination. At the time of examination under the microscope, 
a cover glass was mounted on the slide with immersion oil to enhance 
cellular detail.
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Addition of CTAB to Blood
Solutions of CTAB in absolute ethyl alcohol were freshly pre­
pared. The usual concentration was one mgm per milliliter. To obtain 
dry material for testing, measured amounts of the solution were pipetted 
into clean serological tubes, evaporated to dryness at 60° centigrade, 
and stoppered. Accurate samples of small quantities of CTAB could thus 
be obtained in a stable dry form. The CTAB was reconstituted immediately 
before use by adding 0.2 ml of normal saline. Blood was added to the 
solution and the resultant mixture was gently stirred for a few seconds 
with a wooden applicator stick, thus insuring even distribution of CTAB 
throughout the serum. The latter procedure was found necessary in order 
to prevent gel formation which occurs within a short time with saline 
solutions of CTAB.
Methods Pertinent to Various Experiments 
A Precision Model G-7 (sensitivity C) water bath was em­
ployed in all experiments in which critical control of the incubation 
temperature was essential.
A Beckman Model G pH meter with a calomel electrode (Beckman 
f2?0) was used to determine the effects of variations in pH on the 
phenomenon under study. A glass envelope, filled with saturated MCI 
solution was fitted over the end of the electrode to prevent fibrin de­
posits on the electrode tip. The tip of the glass envelope contained a 
small hole, plugged with cotton, which allowed free passage of the 
electrolyte solution but prevented the serum and cellular elements from 
clogging the electrode tip.
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Experiments were designed to compare the naturally-occurring 
L.E, phenomenon to that produced with CTAB, and to determine if any 
antagonism or augmentation of the two phenomena existed.
The lupus factor was used either as the whole serum from 
patients with lupus erythematosus or was further purified. Purification 
was accomplished by separation of the gamma globulin fraction from serum 
by salt precipitation. The larger globulins were precipitated from the 
serum with the addition of ammonium sulfate until the mixture was 33«3 
per cent saturated. The precipitate was centrifuged and dissolved in six 
ml of normal saline. The globulins were reprecipitated from solution at 
33«3 per cent saturation with ammonium sulfate and again centrifuged.
The precipitate was redissolved in eight ml of distilled water and 
dialyzed in a cellophane bag against tap water for one hour and then 
against distilled water for five hours. Some protein was denatured and 
precipitated from solution. The precipitate was centrifuged and dis­
carded. The dialyzed solution containing the remaining proteins was 
dried by freeze-drying under vacuum, and constitutes the L.E. factor 
fraction referred to in this study.
A control blood or serum sample was run in parallel with each 
experiment.
CHAPTER IV
RESULTS AND DISCUSSION
The morphological changes that occur in cells as the result of 
the L.E, phenomenon have been described by many investigators. The 
sequence of the events of this process has also been investigated. The 
L.E, factor, under suitable circumstances, induces nucleolysis in many 
vrtjite cells. The end-point of this reaction is considered to be the 
formation of the typical L.E. cell as described by Hargraves (l).
Nucleolysis may proceed in various ways and arrive at the same 
end-point. The entire nucleus of a cell may undergo uniform lysis. The 
nucleus swells, becomes a 'smokey-appearing', homogenous mass and the 
nuclear chromatin material disappears. Various amounts of chromatin 
material may remain if the process is not brought to completion. Cyto- 
lysis will then occur, which frees the depolymerized nuclear mass. Any 
remaining chromatin material may continue to depolymerize until it also 
becomes homogeneous. However, this does not always occur and the mass 
may retain small amounts of chromatin material throughout all of the 
events of the phenomenon. The free mass of altered nuclear material is 
thought to exhibit a chemotactic effect upon the remaining normal phago­
cytic cells, and may be phagocytized. Phagocytosis of the free nuclear 
mass by normal white blood cells completes the reaction. A normal phago­
18
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cytic cell engulfs the free nuclear mass and becomes a characteristic 
L.E. cell. However, if depolymerization is not complete at the time of 
phagocytosis, i.e., if some chromatin material remains in the mass, the 
resultant cell is not considered a ’true’ L.E. cell by most investigator^. 
It appears that the formation of the L.E. cell is dependent on the con- I 
centration of the activating factor and the duration of its effect under ; 
optimal circumstances.
The action of the L.E. factor upon the nucleus of a cell is not 
necessarily upon the encire nucleus. In approximately five per cent of 
the affected cells, nucleolysis can be seen in only one or two nuclear ' 
segments of a polymorphonuclear neutrophil while the other segments re­
tain their normal appearance. This segmented nucleolysis with depoly­
merization can continue until the affected nuclear segment enlarges and 
fills the cytoplasm. The remaining, normal-appearing nuclear segments 
are pushed to the periphery of the cell. This cell becomes morphologi­
cally indistinguishable from a cell that has phagocytized a free in­
clusion body. Both cells are identified as L.E. cells, although they 
are formed in different ways.
Various chemical and physical agents may produce nucleolysis, 
either total or segmental, but depolymerization is not usually evident 
under such circumstances. Such cytoplasmic bodies do not show the same 
staining characteristics as the depolymerized material in the L.E. 
preparations.
The criteria for identification of the L.E. cell are based 
upon cellular changes that occur as the result of the L.E. phenomenon. 
Progressive morphological changes that occur in the development of the
20
L.E. cell, were arbitrarily selected to represent a stage in the develop­
ment of the L.E. phenomenon. The following four-point grading system 
was developed as an attempt to quantitate this phenomenon based upon
I
these morphological changes.
Grade I (Color plate I, Figure l). When the first signs of !
depolymerization, i.e., nuclear swelling, could be identified, whether |
segmental or total, the cell was considered to be a Grade I cell (desig-i 
nated by the arrows in Figure l). This condition must be carefully dis-i 
tinguished from the nuclear swelling that normally occurs as blood cells: 
age ’in vitro'.
Grade II (Color plate I, Figure 2). Nucleolysis may be fol­
lowed by cytolysis which leaves the nuclear mass in a free state. Figure 
2 illustrates four different degrees of such nucleolysis, although only : 
one of the cells is considered to be Grade II. The normal lymphocyte in 
the figure is to be disregarded. The center segment of the upper cell in 
the figure is undergoing swelling while the other nuclear segments ap­
pear unaffected. This is another example of a Grade I cell. Directly 
below this cell is a nuclear mass, free of any cytoplasmic boundaries, 
which has been classified as a Grade II lupus cell. This cell reminant, 
or free mass, is to be differentiated from the bottom cell in the diagonal 
of cells. In the latter cell nucleolysis has occurred but not cytolysis, 
and the cytoplasmic Boundaries are still evident. This cell is con­
sidered an intermediate stage between Grade I and Grade II.
The third cell from the top, in the diagonal, is another ex­
ample of a Grade I cell with characteristic swelling evident in all nu­
clear segments.
COLOR PLATE I
Figure 1
Grade I L.E, (Lupus Erythematosus) cell designated ty the 
arrcw. The cytoplasmic and nuclear boundaries are evident but 
the nuclei are swollen and exhibits altered staining proper­
ties. Giemsa stain. 86Cbc
Figure 2
Grade II L.E, (Lupus Erythematosus) cell designated by 
the arrow. Note that cytolysis and nucleolysis have occurred. 
Giemsa stain. 86Cbc
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Grade III (Color Plate II, Figure l). A free nuclear mass or 
Grade II cell is usually incompletely depolymerized and some chromatin 
material is recognizable. If this mass is phagocytized before the com- ; 
plete disappearance of chromatin material, the phagocyte with its in­
clusion body is classified as a Grade III cell (Figure 1, arrow). The 
chromatin material in such a cell is usually evident around the periphery 
of the included mass. This inclusion body may be either a phagocytized 
mass or the result of 'in-situ* depolymerization in a single nuclear seg­
ment, without phagocytosis.
Grade IV (Color Plate II, Figure 2). A Grade IV cell is de­
signated by the arrow in this figure. It is characterized by the normal- 
staining nuclei compressed to the periphery and the large homogeneous 
body contained in the cytoplasm. This cell may have been produced by a 
normal phagocyte which has engulfed extraneous depolymerized nuclear 
material. The inclusion body may have become depolymerized after phagocy­
tosis or the homogeneous cytoplasmic mass might have resulted from de- 
polymerization of one nuclear segment.
Another intermediate stage of one pathway in the L.E. cell 
formation illustrates the chemotaxic properties exerted by the free 
nuclear depolymerized material. This phenomenon, known as 'rosette for­
mation', (Color Plate III, Figure 1), is characterized by many phagocytic 
cells closely surrounding a free, hematoxylin-staining body. The rosette 
is of considerable interest in the survey of slides for evidence of the 
lupus phenomenon. However, the rosette is not always present in the 
L.E. preparations and, consequently, has been omitted in this grading 
system.
COLOR PLATE II
Figure 1
Grade III L.E, (Lupus Erythematosus) cell designated by the 
arrow. Note the chromatin-like material around the periphery of the 
inclusion body, Wright's stain. 860x
Figure 2
Grade IV L,E. (Lupus Erythematosus) cell designated by the 
arrow. The inclusion body appears relatively homogeneous and has
I
displaced the normal-staining nuclei to the periphery of the cell, j
i
Giemsa stain. 860x
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The aforementioned grading system was developed after consider? 
able experience with the various manifestations of the lupus phenomenon 
and appears to express quantitative aspects of both the natural and 
CTAB-produced forms of the process.
i
The first attempt to Induce the L.E.-like cells In normal 
blood by CTAB produced very promising results. Approximately one mgm of 
CTAB powder was placed Into approximately two ml of fresh normal blood. 
After two hours at room temperature a L,E, preparation was made, and all 
cellular changes characteristic of a positive L.E. preparation were 
observed.
The optimal concentration of CTAB and methods for the Intro­
duction of this substance Into the blood were first studied. The ex­
periments, illustrated in Figure I, are examples of several attempts to 
determine the optimal concentration of powdered CTAB necessary to pro­
duce the lupus phenomenon In normal blood. Multiple Grade II cells, 
occasional Grade III, but no Grade IV cells were produced by these ex­
periments . , The erratic response to Increasing concentrations of CTAB 
added In the powdered form Instigated a search for other methods of In­
troducing this agent. Since CTAB precipitates some plasma proteins. It 
Is probably that serum proteins form a precipitated coat around the dry 
powder and interfere with solution of the compound. CTAB was therefore 
added by first dissolving the material In normal saline and adding the 
desired amount of the solution to the blood specimen (Figure II), This 
method was found to produce a more quantitative response and It was ob­
served that concentrations of CTAB of 0.$ mgm/nl of blood to 1.$ mgm/ 
ml of blood produced optimal results. However, a dilution factor had
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been introduced, and it was also found that this solution was not stable. 
It was therefore decided to dissolve CTAB in absolute ethyl alcohol, 
pipette the desired concentration into a dry tube and evaporate off the 
alcohol. This facilitated a more rapid and accurate method for adding 
small amounts of the compound and it was stable indefinitely in the dry ' 
foiTD. Immediately before the addition of blood, 0,2 ml of normal saline i 
was introduced to redissqlve the compound. The blood was then added and 
stirred rapidly to insure even mixing. This method proved to be satis­
factory.
Concentrations of 0.5, 1.0, and I.5 mgm CTAB/ml of blood were 
employed in all experiments to determine the optimal concentration for 
each blood sample. In some instances a wider range of concentrations 
were used. It was found that one mgm CTAB/ml of blood was usually 
optimal (Refer to Tables I and II).
The two experiments illustrated in Figure III demonstrate the 
effects of time and temperature on the artificial L.E. cell phenomenon 
produced with CTAB in normal blood.
It can be seen in Figure Ilia, that incubation of blood-CTAB 
mixtures at temperatures approximating the physiological temperature of 
the cells was unsatisfactory. Within limits, the duration of incubation 
was relatively unimportant, and after 25 minutes, all cells exhibited 
obvious signs of deterioration. In Figure 111^ ,however, conducted at 28 0 
C, (approximately room temperature) Grade III cells were produced after 
two hours of incubation. After three hours only Grade II cells remained 
and there was considerable evidence of cell destruction. Consequently, 
all further experiments in this study were performed at room temperature,,
27
GRADE OF CELLS 
PRODUCED
IV __
Negative _
IIIm #§ ê
1-:^i I
0125 025 05 10 15 20
CONCENTRATION mgm CTAB (saline)/ml BLOOD
RESULTS OF ADDING A SALINE SOLUTION OF CTAB TO BLOOD 
FIGURE II
GRADE OF CELLS
PRODUCED
IV _
I I I
I I
Negative __
EXPERIMENT A 
Temperature 35 • C 
I mgm CTAB/ml Blood
•0 15 20 25
TIME IN MINUTES
30
GRADE OF CELLS 
PRODUCED _ _
IV  _
III _
I I __
Negative __
EXPERIMENT B 
Temperature 28 ®C 
I mgm CTAB /m l Blood
I 2
TIME IN HOURS
rooo
FIGURE Ilia FIGWS Illb
EFFECTS OF TIME AND TEMPERATURE ON TH5 
ARTIFICIAL CTAB-L.E. PHENOMENON
29
using a two hour incubation period.
The production of the artificial L.E. phenomenon with CTAB 
was attempted with freshly drawn blood from 25 individuals. None of the 
group had lupus erythematosus, and it included six normal individuals 
used as controls (Table I). A total of 102 L.E. preparations were made 
using concentrations of CTAB varying from 0.1 mgm to 3.0 mgm/ml of blood. 
The concentration of CTAB which provided optimal nucleolysis with minimal 
cellular destruction was determined for each blood specimen. The optimal 
concentration for the group was found to be 1.0 mgm/ml of blood. Above 
this concentration of CTAB, the majority of cells were lysed, and the 
more advanced cells of the lupus phenomenon had disappeared.
The highest grade of cell produced in the blood of each indivi­
dual and the concentration at which it was produced is recorded in Table 
I. Grade II cells, were the highest grade obtained in 40 per cent of 
these individuals, while Grade III cells appeared in 52 per cent of the 
group. Grade IV, the L.E,-like cell, occurred in two of the 25 individ­
uals or eight per cent of the group. One of the individuals whose serum 
produced Grade IV cells was a normal male and the other a female with a 
diagnosis of degenerative arthritis. There was no apparent difference 
between the response of patients and normal controls with regard to the 
property of forming L.E. cells upon addition of CTAB.
Attempts were made to produce the artificial L.E. phenomenon 
by adding CTAB to blood drawn from various animals and to determine if 
there is a species difference in susceptability to nucleolysis induced by 
CTAB (Table II). A total of 42 animals were employed in this survey in- : 
eluding: ten male and three female dogs, one male and l8 female rats.
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TABLE I
Lupus Erythematosus Cell Production By Grades in Human Blood with Cetyl- 
trimethylammonium Bromide (CTAB) Incubated for Two Hours at Room Temper­
ature .
Patient Sex Diagnosis
Number 
of Ex­
periments
Concentration 
mgm CTAB/ml 
Blood Optimal 
Production
Grade
Cell
Pro­
duced
1. L.I. F Normal 12 1.9 II
2. L.B. F Normal 15 1.5 II
3. C.F. M Normal 5 0.5 II
L.G. M Normal 3 1.0 III
5. J.H. M Normal 3 1.0 IV *
6. B.P. F Normal 3 1.0 III
7. A. J. F Deg. Arth. 5 1.0 III
8. M.B. F Rheu. Arth. 5 0.1-2.0 II
9. B.A. F Deg. Arth. 5 1.0 III
10. L.F. M Rheu. Arth. 3 1.0 III
11. V.D. F Deg. Arth. 3 1.0 IV *
12. S.C. F Rheu. Arth. 3 1.0 II
13. V.L. F Rheu. Arth. 3 1.0 III
Ik. W.L. M Rheu. Arth. 3 1.0 III
15. J.G. F Rheu. Arth. 3 1.0 III
16. L.W. F Rheu. Arth. 3 0.5 II
17. B.T. F Rheu. Arth. 3 1.0 III
18. L.D. F Rheu. Arth. 3 0.5 II
19. M.F, F Bronch. Asthma 2 1.0 III
20. E.H. F Bronch. Asthma 2 1.0 II
21. G.H. M Bronch. Asthma 2 1.0 II
22. J.J. M Bronch. Asthma 2 1.0 II
23. R.H. M Bronch. Asthma,
Cardiac 3 1.0 III
2k. F.P. M Pulm. TBC (?) 3 1.0 III
25. M.G. F Réf. Sh. Dyst. 5 1.0 II
* Grade IV L.E.-like Cells
31
two male and three female rabbits and five female mice with a total of 
9k preparations made with blood from these animals. Grade IV cells 
were produced by CTAB in the blood of one female rat and one male rabbit. 
Grade III cells were produced in the blood of seven male dogs, while the 
remaining animals exhibited only Grade II cells with the exception of 
three dogs and one rabbit, in which CTAB was ineffective in the concen­
trations employed. No significant difference between species or sex was 
apparent and the results with CTAB were similar with all species (Tables 
I and II).
The relatively rare occurrence of Grade IV cells in the CTAB 
preparations, led to further attempts to increase the incidence of the 
typical L.E.-cell stage.
The possibility was considered that a change in pH of the 
blood subsequent to the addition of CTAB, might be an important factor 
in the phenomenon. Blood was collected, under ether anesthesia, from 
normal male rats and pooled for pH studies. The serum was removed from 
a sample of this blood and treated with various concentrations of CTAB. 
Accurate pH readings were recorded at 15 minute intervals over the two 
hour incubation period. The results illustrated in Figure IV show no 
significant variation between CTAB-treated and untreated sera.
When fresh normal blood was exposed to the atmosphere over a 
two hour period a decrease of 0.15 of a pH unit occurred (Figure V).
When L.E. factor was introduced into a sample of this blood, the change 
in pH was slightly greater than that which occurred in the untreated 
sample, but this difference was insignificant. Likewise, when CTAB was 
added to a sample of this blood the pH change was not significantly
TABLE II
Lupus Erythematosus Cell Production By Grades In Normal Animal Blood with Cetyltrimethylam- 
monium Bromide (CTAB) Incubated Two Hours at Room Temperature.
Exp.
No.
No. of 
. Animals 
Used Specie Sex
Number of 
Experiments
Concentrât ion
mgm CTAB/ml of Blood
Optimal Production
Grade Cell 
Produced
32 1 Dog M 2 0.0 Negative
33 1 Dog M 4 0.0 Negative
37 1 Dog F 8 1.0 II
ko 7 Dog F 7 1.0 III
k8 1 Dog F 5 0.5 II
52 1 Dog F 2 0.0 Negative
58 1 Dog M 7 1.0 II
3»^ 2 Bat F 5 1.0 III
53 1 Rat M 4 1.0 II
3^ 1 Rat F 4 0.5 IV *
57 14 Rat F 14 1.0 II
72 1 Rat F 4 1.0 III
36 1 Rabbit m 4 l.C II
41 1 Rabbit F 8 2.0 II
42 1 Rabbit F 4 1.0 II
44 1 Rabbit F 4 0.0 Negative
71 1 Rabb it F 3 1.0 IV *
38 5 Mice F 5 2.0 II
* Grade IV L.E . -like Cells
ro
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different from that of control blood. It was thus felt that pH changes 
could not be held accountable for the lupus-cell-promoting effect of 
this compound, and further studies along this line were abandoned.
The addition of certain cations (calcium, potassium, magnesium 
and zinc) up to one meq/ liter to blood-CTAB mixtures, and the removal 
of calcium with sodium oxalate, did not change the artificial L.B, cell 
phenomenon produced by CTAB.
Clotting is usually retarded by CTAB and in some blood speci­
mens is inhibited entirely; however, the nucleolytic activity of CTAB 
was not altered by the addition of heparin.
Inderbitzen (3) found that the sodium salt of polyvinyl alcohol 
polysulfonic acid ester would induce the artificial L.E. cell phenomenon 
in normal blood only after pre-incubation of this compound with normal 
serum in order to produce or release the active inducing factor. CTAB 
produced the artificial phenomenon without this pre-incubation with 
serum, but in a further attempt to enhance the phenomenon an additional 
factor was introduced (Table III), Serum and CTAB (one mgm/ml of serum) 
were incubated together at varying intervals of time and at different 
temperatures. The serum-CTAB incubated mixtures were rapidly cooled to 
room temperature and added to normal blood (^  ml mixture/ml blood) for 
the artificial L.E. cell preparations. Grade IV cells were produced by 
serum-CTAB mixtures from tubes seven and eight, $0° C for 20 min. and 
500 C. for 30 min. respectively. However, this encouraging result was 
not reproducable, and in three repeated attempts only Grade II and III 
cells were produced in any of the tubes.
In preliminary studies it was found that CTAB will precipitate
34
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some of the plasma proteins and it was also noted here that with in­
creasing temperature the amount of protein precipitated also increased. 
The precipitated protein was of a gummy consistancy and insoluble in '
most protein solvents. When this protein material was added to normal ! 
blood it did not exhibit nucleolytic activity, and chemotajcis was lack- :
I
ing. It was also noted in preliminary studies that CTAB caused rapid 
destruction of all cells in the absence of serum, and it seemed probably
I
that some factor present in serum was necessary to prevent this rapid ' 
destruction. The possibility thus exists that serum proteins act as 
protective agents which inhibit the surface acting cytolytic property of 
CTAB and allow the compound to exert its effect upon the cell nucleus 
instead.
An attempt was made to determine if a portion of the CTAB 
molecule was responsible for its nucleolytic activity, or if the molecule 
functioned as a whole in the production of this effect. The structural 
formula of CTAB is shown in Figure VI along with the formulae of other 
Compounds compared to this agent.
Active constituent groups of the CTAB molecule are illustrated 
and numbered. Other compounds representing these active groups were 
tested. The compounds (Hexaméthonium bromide, cetyl alcohol, cetyltri- 
methyl ammonium chloride, sodium bromide) were added to normal blood in 
concentrations of 0,5, I.5, 2.0, 2.5; and 3.O mgm/^1 of blood, and L.E. 
preparations made after two hours incubation at room temperature. Hexa­
méthonium bromide and cetyl alcohol produced minor cell destruction but 
no other significant results. It was surprising to find that cetyltri- 
metbylammonium chloride produced only Grade II cells in the same blood
37
TABLE III
Effect of Pre-incubâting CTAB With Normal Serum on Producing the Artifi­
cial L.E. Cell Phenomenon in Normal Blood.
(Concentration - 1 mgm CTAB/ml of Serum)
Tube
Minutes Incu­
bation Time 
Temperature °C of Serum
Grade Cell Pro­
duced in Blood
1 1^0 0 / I
2 kO 10 II
3 1^0 20 II
k 1^0 30 III
5 50 0 / II
i 6 50 10 I
! 7 50 20 IV «
8 50 30 IV *
9 60 0 / II
10 60 10 II
11 60 20 II
12 60 30 II
«Grade XV L.E.-like Cell
/ This serum was preheated to the designated temperature, CTAB added 
and then rapidly cooled to room temperature before the addition of 
blood.
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and in the same concentration in which Grade III cells were produced by 
CTAB. Sodium bromide in the concentrations used caused rapid cell de­
struction. Present evidence indicates that CTAB is specific among the 
compounds tested in inducing the artificial L.E. phenomenon.
The serum from patients with systemic lupus erythematosus 
induced the L.E. phenomenon when added to normal blood in proportions of| 
^ ml of L.E, serum to 1 ml of fresh blood. With such natural L.E. cell 
preparations all grades of lupus cells, including rosettes, were found. 
Typical rosettes and L.E. cells produced by natural and artificial means 
are shown in Color Plate III and IV. Figure 1, Color Plate III, illus­
trates a rosette formed in a natural L.E. cell preparation and Figure 2, 
Color Plate III, presents a rosette found in a CTAB-L.E. cell prepara­
tion, In Figure 1, Color Plate IV, numerous Grade III and IV cells from 
a natural L.E. cell preparation are shown and Figure 2, Color Plate IV, 
shows a single Grade IV cell produced by CTAB in normal blood.
The methyl green-pyronin Y (63) staining reagent produced a 
positive reaction in the inclusion bodies of both the natural and arti­
ficially induced Grade IV cells. The authors of the method attributed 
this reaction to the presence of desoxyribose nucleic acid. Ribose 
nucleic acid was found in minute quantities in the cytoplasm of these 
cells by the same reagent. The Feulgen reaction is generally accepted 
as a specific indicator for desoxyribose nucleic acid. The inclusion 
bodies, in the Grade IV cells, were found to be Feulgen positive and 
this correlates with the methyl green-pyronin reaction. No experiments 
were designed to test the hypothesis of Kuemick (57) that the L.E. 
factor inactivates an inhibitor of desoxyribonuclease and permits depoly-
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merization of desoxyribose nucleic acid by this enzyme.
It was found that when CTAB and L.E. factor were added together 
to normal blood the L.E. cell phenomenon was partially or completely 
inhibited. Figure 1, Color Plate V shows the results provided by ad- I
dition of natural L.E. factor to normal blood, and Figure 2 demonstrates|
i
the inhibition in a sample of the same blood when CTAB and L.E. factor |
I
are added together. The process by which this inactivation occurs was 
not investigated but it is likely that CTAB denatures the L.E. factor 
and is likewise consumed in the reaction. This possibility is advanced 
because of evidence that CTAB denatures most of the globulins in serum, : 
and the L.E. factor has been shown to reside in the gamma globulin i
fraction. Color Plate VI further illustrates two cell types with cyto­
plasmic inclusions that are sometimes produced by CTAB but are not sig­
nificant of the L.E. phenomenon. Figure 1 is an example of nucleophago- 
cytosis in which the inclusion body is a normal lymphocyte and Figure 2 
illustrates erythrophagocytosis, in which an erythrocyte is the included 
object.
Nucleophagocytosis and erythrophagocytosis of normal cellular 
elements are thought to indicate stimulation of phagocytosis. These 
phenomena are often found in L.E. preparations, and should not be con­
fused with the Grade IV cell in interpreting the L.E. phenomenon. Al­
though these examples were produced in a CTAB-artificial L.E. cell 
phenomenon, the experimental findings presented in this study suggest 
that phagocytosis is not stimulated and that the primary action of CTAB 
upon a cell is the induction of nuclear break-down. The inability of 
CTAB to produce a greater incidence of Grade IV cells is probably due to
COLOR PLATE III
Figure 1
A "Rosette" found in a natural L.E, (Lupus Erythematosus) 
preparation. Giemsa stain, 860x
Figure 2
A "Rosette" induced by the addition of CTAB to normal blood, 
Wright's stain, 860x
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Figure 1
L.E, (Lupus Erythematosus) cell (Grade IV) found in a 
natural L.E. preparation. Note also numerous Grade II and oc­
cassional Grade III cells present, Wright’s stain. 860x
Figure 2
A Grade TV (L,E.-like Cell) artificially produced by 
CTAB in normal blood, Wright's stain, 860x
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COLOR PLATE V
Figure 1
Nucleolysis induced by the addition of L,E. Factor to 
normal blood, Wright’s stain, 860x
Figure 2
The results of adding L,E, Factor and CTAB together to 
normal blood. Note that nucleolysis is minor and insignifi­
cant, Wright's stain, 860x
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its generalized detrimental effect on all blood cells, only a few sur­
viving which are capable of the dynamic power of phagocytosis. The L.E. | 
factor appears to produce nucleolysis in only selected cells of the | 
population and to stimulate phagocytosis in other cells. j
COLOR PLATE VI
Figure 1 i
Nucleophagocytosis designated by the arrow. The in- |
eluded body appears to be a normal lymphocyte. Giemsa stain, j
860x !
Figure 2
Erythrophagocytosis designated by the arrow. The cell 
has phagocytized a normal-appearing erythrocyte. Wright’s 
stain, 860x
J+5
'■'i
■  . w r i M . .
mÈ^^m
law
;AÜL«i
Figure 1
r
  *
Figure 2
COLOR PLATE VI
CHAPTER V
SUMMARY
The L.E. phenomenon is considered a valuable laboratory aid i
for the diagnosis of systemic lupus erythematosus. The discovery of 
this phenomenon provides considerable impetus to basic and clinical re- ■ 
search in systemic lupus erythematosus and allied diseases. The pheno­
menon has subsequently been reported in other diseases of ground sub­
stance ; hypersensitivity states and in various other disease states.
This abnormal cellular reaction would appear to represent a basic aspect 
of cell pathology. Investigations have resulted in the postulation of 
several interesting mechanisms and pathways leading to the production of 
the phenomenon. Various means of inducing the phenomenon have been re­
ported. Production of this phenomenon in normal blood by chemical means' 
was reported by Inderbitzen (3). The present study has been concerned 
with the investigation of conditions necessary for production of the 
phenomenon and analysis of the cellular changes incidental to it.
The finding that a long chain aliphatic quaternary ammonium 
compound, cetyltrimethylammonium bromide (CTAB), will artificially in­
duce a L.E.-like phenomenon in normal blood has further extended this 
study. The occasional production of true lupus cells with CTAB in 
normal human and animal blood was observed. Lesser manifestations of the
k6
1^7
phenomenon were regularly produced. The typical L.E. cell represents 
the end-point of the L.E. cell reaction, and many recognizable stages oc­
cur in the development of this end-point. A four-point system of grad­
ing, based upon changes in cellular morphology, was designed to quanti­
tate the stage of advancement of this phenomenon. The first recogniz­
able deviation from normal was desipi&ted Grade I and Grade IV, the 
typical L.E, cell, as the end-point of the reaction. Grades II and III 
are intermediate stages in the cellular phenomenon. The rosette, 
another intermediate cellular phenomenon, was not considered in the 
grading system because it was not always found to be present. It was 
determined that a concentration of one mgm of CTAB/ml of blood was 
optimal for the production of this phenomenon. The most satisfactory 
results were obtained after an incubation period of two hours at room 
temperature (approximately 280 0.).
Experiments were designed to determine the most favorable con­
ditions for the action of CTAB and to elucidate the basic mechanism of 
its action.
On the possibility that a shift in acid-base balance of nor­
mal blood might be induced by CTAB and thus account for its action, pH 
determinations were made on normal serum and blood, with and without 
added CTAB, The pH changes produced by CTAB and L.E. factor were almost 
identical, and so minor that they did not warrant further investigation.
Positive (Grade IV) CTAB-L.E. cells were produced with the 
blood of two out of 23 human subjects, one normal and one diagnosed as 
degenerative arthritis. Cetyltrimethylammonium bromide produced L.E.- 
like cells in blood from one rabbit and one rat, among the several
if8
animals tested.
The addition of calcium, magnesium, potassium or zinc did 
not enhance the action of CTAB. The removal of calcium with sodium 
oxalate or the addition of heparin did not alter the reaction.
Preincubation of serum with CTAB, utilizing the technique of 
Inderbitzen, did not enhance production of the lupus phenomenon.
Certain chemical agents, representing component groups of 
the CTAB molecule, were without effect in initiating the lupus pheno­
menon which indicates that the activity is probably dependent upon the 
intact molecule.
The inclusion bodies of both the CTAB-L.E.-like cell and the 
L.E. cell produced with L.E. factor were methyl green-pyronin Y and 
Feulgen positive which indicates the presence of desoxyribose nucleic 
acid and suggests that the two are chemically similar.
When CTAB and the L.E. factor were added together to normal 
blood, the L.E. phenomenonnas inhibited. A probable explanation is 
that CTAB denatures most of the globulins in serum and the L.E. factor 
is thought to be a gamma globulin.
Nucleophagocytosis and erythrophagocytosis are sometimes pro­
duced by CTAB in the artificial L.E. phenomenon, but in general it 
would appear that CTAB is injurious to all cells emd probably does not 
stimulate phagocytosis.
CHAPTER VI 
CONCLUSIONS
1. An artificial L.E. cell phenomenon may he produced in normal human 
and animal blood with CTAB.
2. A system of quantitating the progression of the phenomenon was de­
veloped and used to evaluate the cellular effects produced by CTAB 
under various experimental conditions.
3. Optimal results were obtained at a concentration of one mgm CTAB/ml 
of blood incubated for two hours at approximately 28° centigrade.
4. Shifts in pH were found to be insignificant in the L.E. phenomena 
produced by the L.E. factor as well as that produced by cetyltri­
methylammonium bromide.
5. Neither the addition of calcium, magnesium, potassium or zinc nor 
the removal of calcium altered the action of CTAB.
6. The inhibition of coagulation by heparin or oxalate did not alter 
the reaction.
7. Preincubation of normal serum with CTAB does not significantly alter 
its activity.
8. Chemical agents chosen as representative of the constituent chemical 
groups of the CTAB molecule were tested and found incapable of pro­
ducing the phenomenon, which indicates that the CTAB molecule as
1^9
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such is specific in function.
9* The inclusion bodies of the CTAB-L.E.-like cell and the natural 
L.E. cell were methyl green-pyronin Y and Feulgen positive which 
indicates the presence of desoxyribose nucleic acid.
10. When CTAB and L.E. factors were mixed together in blood the L.E. 
phenomenon is partially or completely inhibited.
11. Indications were found that CTAB is injurious to all cells and 
does not stimulate phagocytosis.
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